{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:28:28Z","timestamp":1791559708290,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Robert Koch-Institut"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p><jats:italic>Chlamydia trachomatis<\/jats:italic> (chlamydia) is a common, frequently asymptomatic, sexually transmitted infection. It can result in severe sequelae, such as ectopic pregnancy and infertility. In Germany, chlamydia is not notifiable. An opportunistic screening program for women\u2009&lt;\u200925\u00a0years was introduced in 2008. The aim of this research was to triangulate different data sources to describe the epidemiological situation of chlamydia in Germany and to investigate whether the current target group of the chlamydia screening program aligns with these findings.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Urine specimens from participants from population-based health examination surveys of children (2014\u201317) and adults (2008\u201311) were tested for chlamydia, using nucleic acid amplification testing. These data were used to generate weighted chlamydia prevalence estimates by age group and sex. Data from a nationwide chlamydia laboratory sentinel system (2014\u201316) were used to calculate the positive proportion among individuals tested for chlamydia by age, sex and test reason.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Using data from the population-based surveys, we found a chlamydia prevalence estimate of 2.8% (95% confidence interval (CI) 1.0\u20137.5%) among all 15- to 17-year-old girls and of 9.6% (95% CI 0.0\u201323) among those reporting to be sexually active. In adult women, we found the highest prevalence among 18- to 24-year-olds (all: 2.3%; 95% CI 1.0\u20135.3%; sexually active: 3.1%; 95% CI 1.3\u20137.0%). In adult men, we found the highest prevalence among 25- to 29-year-olds (all: 3.5%; 95% CI 1.6\u20137.7%; sexually active: 3.3%; 95% CI 1.3\u20137.8%). Data from the chlamydia laboratory sentinel showed the highest positive proportion among those opportunistically screened in 19-year-old women (6.1%; 95%- CI 5.9\u20136.4%), among those screened due to pregnancy in 15-year-old girls (10%; 95% CI 8.5\u201312%), and among those tested due to symptoms or a positive partner in 19-year-old women (10%; 95% CI 9.8\u201311%) and 19-year-old men (24%; 95% CI 22\u201326%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Chlamydia seems to mainly affect adolescents and young adults in Germany, with similar overall prevalence in men and women, but with slightly different age distributions. Women at highest risk of chlamydia are covered by the current screening program but given the on-going discussions in high-income countries on cost-effectiveness and benefit-to-harm ratio of these programs, the program-aim needs reconsideration.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-022-13456-7","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T04:03:59Z","timestamp":1654229039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Prevalence of Chlamydia trachomatis in the general population in Germany \u2013 a triangulation of data from two population-based health surveys and a laboratory sentinel system"],"prefix":"10.1186","volume":"22","author":[{"given":"Martyna","family":"Gassowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Poethko-M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schlaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Sailer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Dehmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane","family":"Bremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Dudareva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Chlamydia trachomatis laboratory sentinel team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Baier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberhard","family":"Straube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Baillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Bartsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Br\u00fcning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Cremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Dall\u00fcgge-Tamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt","family":"Gr\u00f6ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Eicke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Emrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gundula","family":"Fritsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosi","family":"Gjavotchanoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Gohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"G\u00f6tzrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Meye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Ehrhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"K\u00f6pke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Henrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Kastilan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneliese","family":"M\u00e4rzacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerrit","family":"Mohrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Pache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Pf\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Tiemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilmar","family":"Wisplinghoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Aepinus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,3]]},"reference":[{"key":"13456_CR1","first-page":"2021","volume-title":"Accountability for the global health sector strategies 2016\u20132021: actions for impact","author":"World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections","year":"2021","unstructured":"World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections. Accountability for the global health sector strategies 2016\u20132021: actions for impact. Geneva: WHO; 2021. p. 2021."},{"key":"13456_CR2","volume-title":"Chlamydia infection. In: ECDC. Annual Epidemiological Report for 2016","author":"European Centre for Disease Prevention and Control","year":"2018","unstructured":"European Centre for Disease Prevention and Control. Chlamydia infection. In: ECDC. Annual Epidemiological Report for 2016. Stockholm: ECDC; 2018."},{"key":"13456_CR3","volume-title":"Sexually Transmitted Disease Surveillance 2017","author":"Centers for Disease Control and Prevention","year":"2018","unstructured":"Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2017. Atlanta: Department of Health and Human Services; 2018."},{"key":"13456_CR4","volume-title":"Prevalence and incidence of selected sexually transmitted infections, Chlamydia trachomatis, Neisseria gonorrhoeae, syphilis and Trichomonas vaginalis: methods and results used by WHO to generate 2005 estimates","author":"Word Health Organization","year":"2011","unstructured":"Word Health Organization. Prevalence and incidence of selected sexually transmitted infections, Chlamydia trachomatis, Neisseria gonorrhoeae, syphilis and Trichomonas vaginalis: methods and results used by WHO to generate 2005 estimates. Geneva: World Health Organization; 2011."},{"issue":"3","key":"13456_CR5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/cid\/cix769","volume":"66","author":"J Reekie","year":"2018","unstructured":"Reekie J, Donovan B, Guy R, Hocking JS, Kaldor JM, Mak DB, et al. Risk of pelvic inflammatory disease in relation to Chlamydia and gonorrhea testing, repeat testing, and positivity: a population-based cohort study. Clin Infect Dis. 2018;66(3):437\u201343.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"13456_CR6","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/aje\/kws583","volume":"178","author":"MJ Price","year":"2013","unstructured":"Price MJ, Ades AE, De Angelis D, Welton NJ, Macleod J, Soldan K, et al. Risk of pelvic inflammatory disease following Chlamydia trachomatis infection: analysis of prospective studies with a multistate model. Am J Epidemiol. 2013;178(3):484\u201392.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"13456_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1177\/0956462415618837","volume":"27","author":"E Lanjouw","year":"2016","unstructured":"Lanjouw E, Ouburg S, de Vries HJ, Stary A, Radcliffe K, Unemo M. 2015 European guideline on the management of Chlamydia trachomatis infections. Int J STD AIDS. 2016;27(5):333\u201348.","journal-title":"Int J STD AIDS"},{"key":"13456_CR8","unstructured":"Landesuntersuchungsanstalt f\u00fcr das Gesundheits- und Veterin\u00e4rwesen (LUA). Jahresbericht 2020 der Landesuntersuchungsanstalt Sachsen - Tabellenteil. Dresden: LUA; 2021."},{"key":"13456_CR9","doi-asserted-by":"publisher","unstructured":"Bremer V, Dudareva-Vizule S, Buder S, An der Heiden M, Jansen K. Sexuell \u00fcbertragbare Infektionen in Deutschland: Die aktuelle epidemiologische Lage [Sexually transmitted infections in Germany: The current epidemiological situation]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017;60(9):948\u201357. German. https:\/\/doi.org\/10.1007\/s00103-017-2590-1. PMID: 28741188.","DOI":"10.1007\/s00103-017-2590-1"},{"issue":"1","key":"13456_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.17886\/RKI-GBE-2018-032","volume":"3","author":"R Hoffmann","year":"2018","unstructured":"Hoffmann R, Lange M, Butschalowsky H, Houben R, Schmich P, Allen J, et al. KiGGS Wave 2 cross-sectional study - participant acquisition, response rates and representativeness. J Health Monit. 2018;3(1):78\u201391. https:\/\/doi.org\/10.17886\/RKI-GBE-2018-032 PMID: 35586176; PMCID: PMC8848911.","journal-title":"J Health Monit."},{"key":"13456_CR11","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1186\/1471-2458-12-730","volume":"12","author":"C Scheidt-Nave","year":"2012","unstructured":"Scheidt-Nave C, Kamtsiuris P, Gosswald A, Holling H, Lange M, Busch MA, et al. German health interview and examination survey for adults (DEGS) - design, objectives and implementation of the first data collection wave. BMC Public Health. 2012;12:730.","journal-title":"BMC Public Health"},{"issue":"6","key":"13456_CR12","doi-asserted-by":"publisher","first-page":"30459","DOI":"10.2807\/1560-7917.ES.2017.22.6.30459","volume":"22","author":"S Dudareva-Vizule","year":"2017","unstructured":"Dudareva-Vizule S, Haar K, Sailer A, Jansen K, Hamouda O, Wisplinghoff H, et al. Establishment of a voluntary electronic Chlamydia trachomatis laboratory surveillance system in Germany, 2008 to 2014. Euro Surveill. 2017;22(6):30459.","journal-title":"Euro Surveill."},{"key":"13456_CR13","first-page":"469","volume":"46","author":"S Dudareva-Vizule","year":"2013","unstructured":"Dudareva-Vizule S. Chlamydia trachomatis - Laborsentinel. Epidemiologisches. Bulletin. 2013;46:469\u201375.","journal-title":"Bulletin"},{"key":"13456_CR14","doi-asserted-by":"publisher","unstructured":"Kamtsiuris P, Lange M, Hoffmann R, Schaffrath Rosario A, Dahm S, Kuhnert R, et al. Die erste Welle der Studie zur Gesundheit Erwachsener in Deutschland (DEGS1): Stichprobendesign, Response, Gewichtung und Repr\u00e4sentativit\u00e4t [The first wave of the German Health Interview and Examination Survey for Adults (DEGS1): sample design, response, weighting and representativeness]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56(5-6):620-30. German. https:\/\/doi.org\/10.1007\/s00103-012-1650-9. PMID: 23703478.","DOI":"10.1007\/s00103-012-1650-9"},{"key":"13456_CR15","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/1471-2334-13-534","volume":"13","author":"PW Dielissen","year":"2013","unstructured":"Dielissen PW, Teunissen DA, Lagro-Janssen AL. Chlamydia prevalence in the general population: is there a sex difference? a systematic review. BMC Infect Dis. 2013;13:534. https:\/\/doi.org\/10.1186\/1471-2334-13-534.","journal-title":"BMC Infect Dis"},{"key":"13456_CR16","unstructured":"Bode H, He\u00dfling A. Jugendsexualit\u00e4t 2015. Die Perspektive der 14-bis 25-J\u00e4hrigen. Ergebnisse einer aktuellen Repr\u00e4sentativen Wiederholungsbefragung. K\u00f6ln: Bundeszentrale f\u00fcr gesundheitliche Aufkl\u00e4rung; 2015"},{"key":"13456_CR17","doi-asserted-by":"crossref","unstructured":"Heijne JCM, van den Broek IVF, Bruisten SM, van Bergen JEA, de Graaf H, van Benthem BHB. National prevalence estimates of chlamydia and gonorrhoea in the Netherlands. Sexually transmitted infections. 2018","DOI":"10.1136\/sextrans-2017-053478"},{"issue":"3","key":"13456_CR18","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1136\/sextrans-2015-052013","volume":"92","author":"SC Woodhall","year":"2016","unstructured":"Woodhall SC, Soldan K, Sonnenberg P, Mercer CH, Clifton S, Saunders P, et al. Is chlamydia screening and testing in Britain reaching young adults at risk of infection? Findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3). Sex Transm Infect. 2016;92(3):218\u201327.","journal-title":"Sex Transm Infect"},{"issue":"9","key":"13456_CR19","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1055\/s-0043-118284","volume":"77","author":"L Krause","year":"2017","unstructured":"Krause L, Seeling S, Prutz F, Rommel A. Prevalence and Trends in the Utilization of Gynecological Services by Adolescent Girls in Germany. Results of the German Health Survey for Children and Adolescents (KiGGS). Geburtshilfe und Frauenheilkunde. 2017;77(9):1002\u201311.","journal-title":"Geburtshilfe und Frauenheilkunde."},{"key":"13456_CR20","unstructured":"Deutsche STI-Gesellschaft. S2k-Leitlinie: Infektionen mit Chlamydia trachomatis. AWMF Online. 2016;059\/005(08\/2016)."},{"issue":"1","key":"13456_CR21","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1186\/s12879-016-1915-2","volume":"16","author":"A Lallemand","year":"2016","unstructured":"Lallemand A, Bremer V, Jansen K, Nielsen S, Munstermann D, Lucht A, et al. Prevalence of Chlamydia trachomatis infection in women, heterosexual men and MSM visiting HIV counselling institutions in North Rhine-Westphalia, Germany - should Chlamydia testing be scaled up? BMC Infect Dis. 2016;16(1):610.","journal-title":"BMC Infect Dis"},{"issue":"11","key":"13456_CR22","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s00103-021-03319-8","volume":"64","author":"S Matthiesen","year":"2021","unstructured":"Matthiesen S, von Ruden U, Dekker A, Briken P, Cerwenka S, Fedorowicz C, et al. How good is the knowledge about sexually transmitted infections in Germany?\u202f: results of the first nationwide representative German health and sexuality survey (GeSiD). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021;64(11):1355\u201363.","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"13456_CR23","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1186\/s12879-015-1280-6","volume":"15","author":"NH Dukers-Muijrers","year":"2015","unstructured":"Dukers-Muijrers NH, Schachter J, van Liere GA, Wolffs PF, Hoebe CJ. What is needed to guide testing for anorectal and pharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae in women and men? Evidence and opinion BMC infectious diseases. 2015;15:533.","journal-title":"Evidence and opinion BMC infectious diseases"},{"issue":"10156","key":"13456_CR24","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/S0140-6736(18)31816-6","volume":"392","author":"JS Hocking","year":"2018","unstructured":"Hocking JS, Temple-Smith M, Guy R, Donovan B, Braat S, Law M, et al. Population effectiveness of opportunistic chlamydia testing in primary care in Australia: a cluster-randomised controlled trial. Lancet. 2018;392(10156):1413\u201322.","journal-title":"Lancet"},{"issue":"1","key":"13456_CR25","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13643-021-01658-w","volume":"10","author":"J Pillay","year":"2021","unstructured":"Pillay J, Wingert A, MacGregor T, Gates M, Vandermeer B, Hartling L. Screening for chlamydia and\/or gonorrhea in primary health care: systematic reviews on effectiveness and patient preferences. Syst Rev. 2021;10(1):118.","journal-title":"Syst Rev"},{"key":"13456_CR26","volume":"345","author":"IV van den Broek","year":"2012","unstructured":"van den Broek IV, van Bergen JE, Brouwers EE, Fennema JS, Gotz HM, Hoebe CJ, et al. Effectiveness of yearly, register based screening for chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementation. BMJ (Clinical research ed). 2012;345: e4316.","journal-title":"BMJ (Clinical research ed)"},{"issue":"10309","key":"13456_CR27","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/S0140-6736(21)02002-X","volume":"398","author":"N Low","year":"2021","unstructured":"Low N, Hocking JS, van Bergen J. The changing landscape of chlamydia control strategies. Lancet. 2021;398(10309):1386\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(21)02002-X Epub 2021 Sep 22 PMID: 34562393.","journal-title":"Lancet."},{"issue":"7","key":"13456_CR28","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1136\/sextrans-2021-055130","volume":"97","author":"K Soldan","year":"2021","unstructured":"Soldan K, Anyalechi GE, Kreisel KM, Hocking JS, Bernstein K. The Great Chlamydia Control Bake Off: the same ingredients (evidence) but different recipes for success. Sex Transm Infect. 2021;97(7):473\u20135.","journal-title":"Sex Transm Infect"},{"issue":"7","key":"13456_CR29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1136\/sextrans-2021-054992","volume":"97","author":"J van Bergen","year":"2021","unstructured":"van Bergen J, Hoenderboom BM, David S, Deug F, Heijne JCM, van Aar F, et al. Where to go to in chlamydia control? From infection control towards infectious disease control. Sex Transm Infect. 2021;97(7):501\u20136.","journal-title":"Sex Transm Infect"},{"issue":"1","key":"13456_CR30","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/s12879-018-3323-2","volume":"18","author":"AS Lang","year":"2018","unstructured":"Lang AS, An der Heiden M, Jansen K, Sailer A, Bremer V, Dudareva S, et al. Not again! Effect of previous test results, age group and reason for testing on (re-)infection with Chlamydia trachomatis in Germany. BMC Infect Dis. 2018;18(1):424.","journal-title":"BMC Infect Dis"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-13456-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-022-13456-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-13456-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T04:04:25Z","timestamp":1654229065000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-022-13456-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,3]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["13456"],"URL":"https:\/\/doi.org\/10.1186\/s12889-022-13456-7","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,3]]},"assertion":[{"value":"15 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The health examination survey of children and adolescents received ethical approval from Hannover Medical School\u2019s ethics committee in 2014 (No. 2275\u20132014), the amendment for the testing of urine for chlamydia was approved on October 27<sup>th<\/sup> 2017. The health examination survey of adults received ethical approval from Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin ethics committee in September 2008 (No. EA2\/047\/08). The approval for further use of collected biological samples was included in the informed consent form of the respective survey and was collected in written form prior to study participation (in case of minor participants, consent was collected from legal guardians).As the chlamydia laboratory sentinel system only collects data generated as a result of routine testing and no additional tests are performed on the samples, no ethical approval was required for the establishment of the system. Due to these facts, and that no patient-identifying data are collected, informed consent of the participants was not necessary.All three study protocols were reviewed and approved by the Federal Commissioner for Data Protection and Freedom of Information prior to begin of data collection. All methods of the two surveys and of the laboratory sentinel system from chlamydia were carried out in accordance with all relevant guidelines and regulation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KJ is member of the editorial board at BMC Infectious Diseases. None of the authors declares competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1107"}}